Works matching AU Šamec, Neja

Results: 14

From Biomarker Discovery to Clinical Applications of Metabolomics in Glioblastoma.

Published in:

Metabolites (2218-1989), 2025, v. 15, n. 5, p. 295, doi. 10.3390/metabo15050295

By:

Šamec, Neja;
Krapež, Gloria;
Skubic, Cene;
Jovčevska, Ivana;
Videtič Paska, Alja

Publication type:

Article

OligoPrime: An Information System for Oligonucleotide Management.

Published in:

Biomedical Engineering & Computational Biology, 2021, p. 1, doi. 10.1177/11795972211041983

By:

Ravnik, Šimen;
Žabkar, Ines;
Prosenc Zmrzljak, Uršula;
Jovčevska, Ivana;
Šamec, Neja;
Moškon, Miha;
Videtič Paska, Alja

Publication type:

Article

OligoPrime: An Information System for Oligonucleotide Management.

Published in:

Biomedical Engineering & Computational Biology, 2021, p. 1, doi. 10.1177/11795972211041983

By:

Ravnik, Šimen;
Žabkar, Ines;
Prosenc Zmrzljak, Uršula;
Jovčevska, Ivana;
Šamec, Neja;
Moškon, Miha;
Videtič Paska, Alja

Publication type:

Article

In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.

Published in:

Antibodies (2073-4468), 2025, v. 14, n. 1, p. 8, doi. 10.3390/antib14010008

By:

Krapež, Gloria;
Šamec, Neja;
Zottel, Alja;
Katrašnik, Mojca;
Kump, Ana;
Šribar, Jernej;
Križaj, Igor;
Stojan, Jurij;
Romih, Rok;
Bajc, Gregor;
Butala, Matej;
Muyldermans, Serge;
Jovčevska, Ivana

Publication type:

Article

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.

Published in:

Cancers, 2023, v. 15, n. 3, p. 573, doi. 10.3390/cancers15030573

By:

Zottel, Alja;
Novak, Metka;
Šamec, Neja;
Majc, Bernarda;
Colja, Sara;
Katrašnik, Mojca;
Vittori, Miloš;
Hrastar, Barbara;
Rotter, Ana;
Porčnik, Andrej;
Lah Turnšek, Tamara;
Komel, Radovan;
Breznik, Barbara;
Jovčevska, Ivana

Publication type:

Article

Current Technologies for RNA-Directed Liquid Diagnostics.

Published in:

Cancers, 2021, v. 13, n. 20, p. 5060, doi. 10.3390/cancers13205060

By:

Martinez-Dominguez, Maria Victoria;
Zottel, Alja;
Šamec, Neja;
Jovčevska, Ivana;
Dincer, Can;
Kahlert, Ulf Dietrich;
Nickel, Ann-Christin

Publication type:

Article

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas.

Published in:

Cancers, 2021, v. 13, n. 16, p. 4117, doi. 10.3390/cancers13164117

By:

Zolotovskaia, Marianna;
Tkachev, Victor;
Sorokin, Maxim;
Garazha, Andrew;
Kim, Ella;
Kantelhardt, Sven Rainer;
Bikar, Sven-Ernö;
Zottel, Alja;
Šamec, Neja;
Kuzmin, Denis;
Sprang, Bettina;
Moisseev, Alexey;
Giese, Alf;
Efimov, Victor;
Jovčevska, Ivana;
Buzdin, Anton

Publication type:

Article

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.

Published in:

Cancers, 2021, v. 13, n. 14, p. 3419, doi. 10.3390/cancers13143419

By:

Sorokin, Maxim;
Raevskiy, Mikhail;
Zottel, Alja;
Šamec, Neja;
Skoblar Vidmar, Marija;
Matjašič, Alenka;
Zupan, Andrej;
Mlakar, Jernej;
Suntsova, Maria;
Kuzmin, Denis V.;
Buzdin, Anton;
Jovčevska, Ivana

Publication type:

Article

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs.

Published in:

Cancers, 2020, v. 12, n. 7, p. 1842, doi. 10.3390/cancers12071842

By:

Zottel, Alja;
Šamec, Neja;
Videtič Paska, Alja;
Jovčevska, Ivana

Publication type:

Article

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.

Published in:

Cancers, 2019, v. 11, n. 8, p. 1060, doi. 10.3390/cancers11081060

By:

Jovčevska, Ivana;
Zottel, Alja;
Šamec, Neja;
Mlakar, Jernej;
Sorokin, Maxim;
Nikitin, Daniil;
Buzdin, Anton A.;
Komel, Radovan

Publication type:

Article

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.

Published in:

Molecules, 2021, v. 26, n. 17, p. 5141, doi. 10.3390/molecules26175141

By:

Porčnik, Andrej;
Novak, Metka;
Breznik, Barbara;
Majc, Bernarda;
Hrastar, Barbara;
Šamec, Neja;
Zottel, Alja;
Jovčevska, Ivana;
Vittori, Miloš;
Rotter, Ana;
Komel, Radovan;
Lah Turnšek, Tamara

Publication type:

Article

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.

Published in:

Molecules, 2020, v. 25, n. 3, p. 490, doi. 10.3390/molecules25030490

By:

Šamec, Neja;
Zottel, Alja;
Videtič Paska, Alja;
Jovčevska, Ivana;
Pastorino, Fabio;
Brignole, Chiara

Publication type:

Article

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration.

Published in:

Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920915302

By:

Zottel, Alja;
Jovčevska, Ivana;
Šamec, Neja;
Mlakar, Jernej;
Šribar, Jernej;
Križaj, Igor;
Skoblar Vidmar, Marija;
Komel, Radovan

Publication type:

Article

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8491, doi. 10.3390/ijms21228491

By:

Zottel, Alja;
Šamec, Neja;
Kump, Ana;
Dall'Olio, Lucija Raspor;
Pužar Dominkuš, Pia;
Romih, Rok;
Hudoklin, Samo;
Mlakar, Jernej;
Nikitin, Daniil;
Sorokin, Maxim;
Buzdin, Anton;
Jovčevska, Ivana;
Komel, Radovan

Publication type:

Article